Further studies on the therapeutic effect of indomethacin on esophageal tumors
Open Access
- 1 September 1986
- Vol. 58 (5) , 1029-1031
- https://doi.org/10.1002/1097-0142(19860901)58:5<1029::aid-cncr2820580508>3.0.co;2-d
Abstract
The effect of treatment with the nonsteroid anti‐inflammatory drug indomethacin, was investigated in 250 3‐month‐old C57B1 female mice following induction of esophageal tumors with diethylnitrosamine (DEN). Already 3 months after DEN treatment, many esophageal tumors were committed to occur: despite discontinued DEN treatment, the number of tumors had increased significantly at 6 or 9 months of observation. Following 3 and 4 months of DEN administration, the development of many already committed esophageal tumors was significantly abrogated by treating the mice with indomethacin. Cancer 58:1029‐1031, 1986.This publication has 7 references indexed in Scilit:
- The influence of prostaglandin antagonists on radiation therapy of carcinoma of the cervixGynecologic Oncology, 1984
- Prostaglandins and human lung carcinomasBritish Journal of Cancer, 1982
- Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapyCancer, 1982
- Prostaglandins and Host Defense in CancerMedical Clinics of North America, 1981
- Review: Prostaglandins and cancerProstaglandins and Medicine, 1980
- Prostaglandin E and cancer GrowthCancer Immunology, Immunotherapy, 1980
- Direct immunochemical detection of prostaglandin-e and cyclic nucleotides in human malignant tumorsCancer, 1977